PA
SWAV

Probity Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Probity Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,902
Closed -$619K – 216
2024
Q1 		$619K Buy
1,902
+29
+2% +$7.12K 0.13% 128
2023
Q4 		$357K Buy
1,873
+46
+3% +$8.69K 0.08% 167
2023
Q3 		$364K Buy
1,827
+27
+2% +$6.38K 0.08% 143
2023
Q2 		$514K Buy
+1,800
New +$500K 0.11% 121
2022
Q4 		$379K Buy
1,841
+10
+0.5% +$2.53K 0.09% 143
2022
Q3 		$509K Sell
1,831
-23
-1% -$5.85K 0.13% 107
2022
Q2 		$354K Sell
1,854
-49
-3% -$8.65K 0.08% 142
2022
Q1 		$395K Sell
1,903
-3
-0.2% -$495 0.08% 144
2021
Q4 		$340K Sell
1,906
-6
-0.3% -$1.18K 0.07% 163
2021
Q3 		$394K Buy
1,912
+19
+1% +$3.73K 0.08% 153
2021
Q2 		$359K Sell
1,893
-63
-3% -$10.3K 0.08% 153
2021
Q1 		$255K Buy
+1,956
New +$235K 0.06% 176

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Probity Advisors's SWAV Position: Q2 2024 in Review

Probity Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,902 shares — an estimated $619K sold.

Probity Advisors first reported a position in SWAV in Q1 2021 and held it in 12 quarters. The position peaked at $619K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Probity Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Probity Advisors sold 1,902 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $619K.
  • Probity Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Probity Advisors's Shockwave Medical, Inc. Common Stock position peaked at $619K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Probity Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.